Celiac disease affects about 1% of the global population, but most cases in developed countries remain undiagnosed. The available evidence combines screening estimates, recorded diagnoses, administrative data, mortality coding, and self-reported diet surveys, so each figure needs its population, period, and measurement definition.
Key Celiac Disease Statistics
The most broadly useful figures are:
- In review evidence through 2020, about 1% of the global population was estimated to have celiac disease.
- In review evidence through 2020, 83% to 95% of cases in developed countries were estimated to remain undiagnosed.
- In review evidence through 2020, the estimated U.S. prevalence was approximately 0.71%.
- In 21st-century population-based studies worldwide, pooled incidence was 17.4 per 100,000 person-years among females.
- In 21st-century population-based studies worldwide, pooled incidence was 7.8 per 100,000 person-years among males.
- In 21st-century population-based studies, pooled incidence was 21.3 per 100,000 person-years among children.
- In 21st-century population-based studies, pooled incidence was 12.9 per 100,000 person-years among adults.
- In the United Kingdom from 1990 to 2011, 9,087 incident celiac disease cases were identified in the CPRD.
- In the United Kingdom from 1990 to 2011, recorded incidence was 13.8 per 100,000 person-years overall.
- In the United Kingdom from 1990 to 2011, female recorded incidence was 17.93 per 100,000 person-years.
- In the United Kingdom across 1990–2011, overall recorded incidence rose from 5.2 to 19.1 per 100,000 person-years.
- In the United Kingdom in 2011, about 12,000 people were estimated to receive a new diagnosis.
- In review evidence through 2020, prevalence among first-degree relatives was reported at 10% to 20%.
- In 2019, fewer than 1,000 U.S. deaths involved celiac disease under the report’s coding definition.
- In 2018-era U.S. claims data, claims-based prevalence was 0.1% among privately insured enrollees.
- Six months after diagnosis in a 105-adult cohort, 91% reported gluten exposure less than once per month.
- In a North East England survey, 40% of 287 adults reported intentional gluten consumption.
- In a seven-hospital Spanish study, 71.5% of 366 adults reported perfect treatment adherence.
Contents
- Global celiac disease prevalence and the diagnosed gap
- Celiac disease incidence by sex, age, and region
- Celiac disease trends over time
- Higher-risk groups and associated conditions
- Celiac disease outcomes, mortality, and U.S. burden
- Gluten-free diet adherence and exposure
Global Celiac Disease Prevalence and the Diagnosed Gap
The review Celiac disease: Understandings in diagnostic, nutritional, and medicinal aspects summarizes prevalence through 2020. Its global estimate is about 1% of the general population, while reported prevalence in Europe and North America ranges from 0.5% to 1%.
The measurement method changes the result. The review reports 0.7% prevalence for biopsy-confirmed cases and 1.4% when based on serological screening; these are different measures and should not be treated as interchangeable. Celiac disease: Understandings in diagnostic, nutritional, and medicinal aspects
| Geography or measure | Reported estimate | Period and definition |
|---|---|---|
| Global general population | About 1% | Review evidence through 2020 |
| Europe and North America | 0.5%–1% | Review range using differing serology and biopsy definitions |
| Biopsy-confirmed cases | 0.7% | Global studies summarized in the review |
| Serological screening | 1.4% | Global studies summarized in the review |
| United States | Approximately 0.71% | Review estimate through 2020 |
Regional estimates also vary. The review reports 0.4% in South America, 0.5% in Africa, and 0.8% in Europe, while some studies in Finland and Sweden report 2% to 3%; a cited estimate for Saudi Arabia reaches 3.2%.
The central diagnosis gap is large: 83% to 95% of cases in developed countries were estimated to remain undiagnosed. A U.S. research-plan estimate cited in the review described roughly 3 million people with celiac disease, or about 1 in 133 people, but that older estimate is not equivalent to confirmed diagnosed cases.
Celiac Disease Incidence by Sex, Age, and Region
The systematic review and meta-analysis Incidence of Celiac Disease Is Increasing Over Time pooled 21st-century population-based studies. It estimated incidence at 17.4 per 100,000 person-years among females and 7.8 among males, with very high heterogeneity: I² was 99.5% for females and 98.6% for males.
Age-specific pooled incidence was 21.3 per 100,000 person-years among children and 12.9 among adults. Age definitions and case ascertainment varied across studies, so these estimates summarize heterogeneous populations rather than a single universal rate. Incidence of Celiac Disease Is Increasing Over Time: A Systematic Review and Meta-analysis
The UK population-based CPRD study identified 9,087 incident cases from 1990 to 2011 and recorded 13.8 cases per 100,000 person-years overall.
| UK CPRD group, 1990–2011 | Incidence per 100,000 person-years |
|---|---|
| Males | 9.60 |
| Females | 17.93 |
| Under age 5 | 15.29 |
| Ages 5–17 | 9.16 |
| Ages 18–29 | 9.07 |
The UK study found incidence nearly twice as high in females as males, with an adjusted incidence rate ratio of 1.85. The highest recorded incidence occurred among children under 5 and adults ages 50–69, producing a bimodal age pattern.
Regional UK values ranged from 22.3 per 100,000 person-years in Northern Ireland, the highest reported value, to 10 in London, the lowest reported value. These are regional primary-care comparisons, not screening prevalence estimates. Incidence and Prevalence of Celiac Disease and Dermatitis Herpetiformis in the UK Over Two Decades: Population-Based Study
Celiac Disease Trends Over Time
The pooled meta-analysis estimated that incidence increased by 7.5% per year over the past several decades covered by its included studies. Because settings and methods differed substantially, the trend does not establish one cause.
The UK record provides a more specific 22-year view. Overall recorded incidence rose from 5.2 to 19.1 per 100,000 person-years between 1990 and 2011, while the adjusted overall incidence rate ratio was 1.06 per calendar year.
The UK age trends were uneven:
- Incidence among ages 5–17 increased by about 9% annually, with an adjusted IRR of 1.09.
- Incidence among ages 18–29 also increased by about 9% annually, with an adjusted IRR of 1.09.
- Incidence among people age 30 and older increased approximately 4% to 7% per year.
- Incidence among children under 5 remained relatively constant, with an annual IRR of 1.01.
The study estimated about 12,000 new UK diagnoses in 2011. These were recorded or extrapolated diagnoses, so changes may reflect awareness, testing, access, and coding as well as underlying disease occurrence. UK population-based study
Higher-Risk Groups and Associated Conditions
The review evidence through 2020 reports higher celiac disease prevalence in several clinical and familial groups. The ranges differ because of screening design, age, genetic background, and referral patterns.
| Group | Reported prevalence range |
|---|---|
| First-degree relatives | 10%–20% |
| Type 1 diabetes | 1%–12% |
| Autoimmune thyroid disease | 2%–6% |
| Down syndrome | 2%–6% |
| Autoimmune hepatitis | 3%–7% |
| Turner syndrome | 4%–5% |
| Iron-deficiency anemia | 3%–15% |
| Osteoporosis | 1%–3% |
The first-degree-relative range is reported at 10% to 20%, but risk varies with the exact relationship, HLA status, and screening protocol. The autoimmune thyroid disease range is a review summary rather than the pooled result of the separate meta-analysis listed in the source materials.
These figures describe selected populations and should not be applied as general-population prevalence. Celiac disease: Understandings in diagnostic, nutritional, and medicinal aspects
Celiac Disease Outcomes, Mortality, and U.S. Burden
The NIDDK report Celiac Disease – Burden of Digestive Diseases in the United States uses administrative and death-certificate data. In 2019, celiac disease contributed to fewer than 1,000 U.S. deaths under the report’s definition, and the mortality table showed the highest mortality rates among people age 75 and older.
Claims data show a different scale from screening studies. Among privately insured U.S. enrollees, claims-based prevalence was 0.1% when all-listed diagnoses were counted in 2018-era data.
This substantially understates undiagnosed disease and is not a screening prevalence estimate.
The measures answer different questions: death certificates capture coded deaths, claims capture diagnosed or recorded conditions in an insured population, and screening estimates attempt to identify disease whether or not it has been clinically diagnosed. Celiac Disease – Burden of Digestive Diseases in the United States
Gluten-Free Diet Adherence and Gluten Exposure
Diet figures are cohort- and instrument-specific. They often measure self-reported exposure rather than a laboratory-confirmed gluten dose, so survey percentages should not be combined into one adherence rate.
In a prospective cohort of 105 newly diagnosed biopsy-confirmed adults, 91% reported gluten exposure less than once per month at six months. The same cohort reported a suspected symptomatic reaction to gluten in 66% of participants, and among participants reporting exposure, 63% said they did not suspect gluten until a reaction occurred.
Reported exposure categories in that cohort included restaurant ordering problems at 29% of reported suspected exposures, cross-contact at 30%, and a major gluten-containing ingredient at 10%. The cohort was 69% female, which describes its sample composition rather than population sex distribution. Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten-free diet
Other surveys illustrate how definitions and settings change the result:
- In a North East England survey of 287 adults, 40% reported intentional gluten consumption.
- In a seven-hospital Spanish study of 366 adults, 71.5% reported perfect treatment adherence, 23.5% reported inadvertent poor adherence, and 5% reported intentional poor adherence.
- In a Canadian survey of 82 people with a median six years of gluten-free-diet experience, 55% reported strict adherence, 21% reported inadvertent gluten consumption, and 18% reported intentional gluten consumption.
In a separate 105-person cohort, 26% reported no gluten exposure and 66% reported infrequent exposure below once per month at six months. These categories came from the GF-EAT instrument and should not be combined as independent populations. Challenges of Monitoring the Gluten-Free Diet Adherence in the Management and Follow-Up of Patients with Celiac Disease